Company Overview

Development Stage

About the Company

Beijing Chu Yangliu Hospital was officially established in 1973, formerly known as the Chu Yangliu Outpatient Department, which was founded in 1968. In 2004, it was additionally named Beijing Minimally Invasive Hospital. It is a tertiary comprehensive hospital sponsored by the Chaoyang District Government of Beijing, integrating medical care, teaching, research, and prevention. It is designated as a regional medical center by the Beijing municipal government and serves as the leading unit of the Southern Chaoyang Medical Consortium. It is affiliated with Tsinghua University, and serves as a teaching hospital for Hebei Medical University and North China University of Science and Technology. It is also a National Drug Clinical Trial Institution and a Class A designated medical institution for Beijing medical insurance.

The hospital has a total building area of 117,300 square meters and a planned bed capacity of 750. It currently has more than 1,400 employees, including nearly 1,100 professional and technical personnel, over 360 with doctoral or master's degrees, and more than 170 with associate senior titles or above. There are 2 doctoral supervisors and 29 master's supervisors. The hospital sets up 56 clinical and medical technology departments, with strong comprehensive diagnosis and treatment capabilities. The annual outpatient and emergency visits are about 1 million, with about 25,000 inpatient admissions and over 10,000 surgical cases per year.

The hospital is equipped with advanced medical devices, including a 3.0T high-quality magnetic resonance imaging system, a 256-slice ultra-high-end CT, digital subtraction angiography X-ray machines, digital color ultrasound diagnostic instruments, intravascular ultrasound diagnostic instruments, flat-panel digital gastrointestinal angiography machines, automated intelligent blood collection management systems, automated biochemical and immunological testing lines, surgical robots, surgical navigation and positioning systems, surgical microscopes, 4K high-definition laparoscopes, high-frequency oscillatory ventilators, extracorporeal membrane oxygenation (ECMO) machines, heart failure ultrafiltration machines, laser lithotripsy treatment instruments, full-line dental equipment, a complete set of digital digestive endoscopy systems, and laminar flow purification operating rooms with integrated surgical control systems, thereby possessing the fundamental conditions of a modern hospital.

The hospital has intensified efforts in talent cultivation and introduction. With the support of the Chaoyang District Health Commission's policy of flexibly introducing external experts, over the past five years, multiple specialties, including the Cardiovascular Disease Center, Bone and Joint Disease Center, Neurological Disease Center, Digestive Disease Center, and Nephrology Department, have successively introduced influential academic leaders and appointed 13 well-known domestic experts and professors. Additionally, 214 doctors and nurses were sent to top-tier hospitals for further training, and 15 went abroad for advanced studies. The talent echelon construction is becoming increasingly complete, greatly enhancing the clinical diagnosis and treatment capabilities of various specialties.

Currently, the hospital has 3 Beijing municipal key clinical cultivation specialties: General Surgery, Respiratory Medicine, and Clinical Laboratory. It also has 2 district-level key disciplines: Orthopedics and Urology. In March 2021, it passed the qualification certification as a drug clinical trial institution, and its Cardiology, Orthopedics, and Hematology departments possess relevant professional qualifications, opening a new chapter in drug clinical trials and scientific research and broadening the scope of research work.

The hospital's Chest Pain Center has passed the certification of the China Chest Pain Alliance and is a standard version of the Chest Pain Center. The Stroke Center has passed the certification of the National Health Commission's Stroke Prevention and Control Committee and is a demonstration stroke center. Both centers have passed the certification of the Beijing Quality Control Center, playing an important role in emergency treatment of cardiovascular and cerebrovascular diseases. The Medical Imaging Center has passed the Beijing-Tianjin-Hebei integration certification, and the laboratory center has 42 items mutually recognized in the Beijing-Tianjin-Hebei laboratory results mutual recognition program.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 1,355万(元)
Legal Representative: 陈方
Credit Code: 12110105400833407C
Registered Address: 北京市朝阳区垂杨柳南里2号

People who follow this company also follow

Competitors (Similar Companies)

生物医药 原料药 化学制药 糖浆剂
健康管理 医疗服务 女性健康 高端医疗
“7个产品的国家行业标准起草单位”
“Internationally renowned, domestically top-tier”
“A modern pharmaceutical enterprise spanning three major fields: modern”
招投标 基础设施建设 交通基础设施 交通枢纽
彩超 临床诊断 生化分析 血压检测仪
医院 骨科医院 骨科 显微外科
垃圾分类 环保/节能 环保工程 环境治理
超声乳化仪 体检中心 社区卫生服务 保健
“Pharmaceutical and Health Industry Group”
塑料容器 生产 塑料包装容器 塑料制品
彩超 免疫分析 肿瘤医院 医保定点

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates